about
Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study.Monitoring of adherence to headache treatments by means of hair analysis.Medication overuse and chronic migraine: a critical review according to clinical pharmacology.Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal.Hair testing in clinical setting: Simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS.Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy.Glutamate receptor antagonists with the potential for migraine treatment.Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair.The association between migraine and physical exercisePolypharmacy Among Headache Patients: A Cross-Sectional StudyA case-control study of visually evoked postural responses in childhood with primary headachesSeizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017Easy tools to screen Italian women suffering from migraine with and without aura in early reproductive ageIntra-patient variability of the hair levels of pain medications in chronic migraine patients - a pilot studySecondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers: A case-control studyExploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache
P50
Q36869674-37F265D9-27E3-4143-AF6F-1ADFE3C76CB9Q37166083-A9120E3D-CDBA-4053-83E3-E838371DA2E3Q37580839-91965996-493F-4A47-AB67-5B201E11B816Q38509398-1F806B82-35D2-4958-8098-941CD171EAA8Q39449789-CF1CEC4E-CFA4-4132-89DF-29C13AFCD3E0Q39803298-6E1856E6-D8A6-459A-9702-8E3EEFDE34D0Q47133621-F63230A1-F17E-4732-9D6C-C2C227128F22Q47627647-81165CE7-AA6B-4545-89B5-A2FBA43DE382Q47858450-C16D0481-8AD6-4F37-B800-586CF776D3B7Q57159055-CA4D58F1-93EC-4744-8F18-18E5E73E9276Q58896340-3B2097EE-5CE1-4FF9-A5B0-E955AA9E9ED9Q90008321-0ED055B3-4A82-4FB8-A913-4ECE834ACDF0Q90166643-8A620122-D3B8-4682-9949-C63005CAA650Q90347628-69FA9C07-DC6E-408A-A3A2-9DC71B502495Q90704102-FD0B14C9-CCE0-4C07-AC99-C77F73970E53Q90743466-00FC78A5-AE93-4F3D-A16C-506D057879F1Q90777360-6BB264B4-9DB8-49A2-9D00-F29CEC4296A8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlo Baraldi
@ast
Carlo Baraldi
@en
Carlo Baraldi
@es
Carlo Baraldi
@nl
Carlo Baraldi
@sl
type
label
Carlo Baraldi
@ast
Carlo Baraldi
@en
Carlo Baraldi
@es
Carlo Baraldi
@nl
Carlo Baraldi
@sl
prefLabel
Carlo Baraldi
@ast
Carlo Baraldi
@en
Carlo Baraldi
@es
Carlo Baraldi
@nl
Carlo Baraldi
@sl
P106
P1153
56684807200
P21
P31
P496
0000-0001-8432-1888